# Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia

> **NCT01673490** · PHASE4 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 59 (actual)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **DRUG:** Dutasteride/Tamsulosin

## Key facts

- **NCT ID:** NCT01673490
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06-29
- **Primary completion:** 2015-03-20
- **Final completion:** 2015-03-20
- **Target enrollment:** 59 (ACTUAL)
- **Why stopped:** The sole investigative site refused to accept the amended protocol and declined to continue the study. There was no safety signal nor any other reason.
- **Last updated:** 2018-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01673490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01673490, "Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01673490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*